Eduard Enrico Holdener
Chairman at NOVIMMUNE SA
Network origin in Eduard Enrico Holdener first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
61
| Subsidiary | Pharmaceuticals: Major | 61 |
| Public Company | Pharmaceuticals: Major | 36 | |
| Holding Company | Miscellaneous Commercial Services | 29 | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.
15
| Subsidiary | Pharmaceuticals: Generic | 15 |
14
| Subsidiary | Medical/Nursing Services | 14 |
University of Basel
9
| College/University | Other Consumer Services | 9 |
| Venture Capital Fund | Investment Managers | 7 | |
Swiss Cancer Foundation
3
| Foundation/Endowment | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Eduard Enrico Holdener via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chairman | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of St. Gallen | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Director/Board Member Undergraduate Degree Masters Business Admin | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer Chief Executive Officer | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member Chairman Director/Board Member | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BB BIOTECH AG | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
| University of Innsbruck | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chief Executive Officer Chairman | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Private Equity Investor | |
Okairos AG
 Okairos AG Pharmaceuticals: MajorHealth Technology Okairos AG develops preventive and therapeutic vaccines against human chronic infectious diseases. Its products include genetic vaccines, adenovirus vector platform, and proprietary cell line. The company was founded by Riccardo Cortese, Alfredo Nicosia, and Antonella Folgori in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance Boston Millennia Partners (BMP) is a private equity and venture capital subsidiary of Glen Ventures Management, Inc founded in 1997 by Dana Callow. The firm headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| Instituto de Empresa SL | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Friends of Phelophepa Foundation | Chairman Chairman | ||
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Vivet Therapeutics SAS develops novel gene therapy treatments for inherited metabolic diseases. The firm offers its services under the categorizers of Biopharma, Biotechnology and Health Care. The company was founded by Jean-Philippe Combal, Gloria Gonzalez-Aseguinolaza and Jens Kurth on July 26, 2016 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Chairman | |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Comptroller/Controller/Auditor Corporate Officer/Principal | |
WWF International
 WWF International Miscellaneous Commercial ServicesCommercial Services WWF International provides environmental conservation services. It focus on Our Global Goals, Priority Species, Priority Places and Reducing Impacts services. The company was founded in April 29, 1961 and is headquartered in Gland, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| PHILIPS NV | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Universidad Complutense de Madrid | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin | |
Pamplona Capital Management LLP
 Pamplona Capital Management LLP Investment ManagersFinance Pamplona Capital Management LLP (Pamplona Capital Management) is a private equity firm founded in 2005 by Alexander Mark Knaster. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Freiburg | College/University | Corporate Officer/Principal Doctorate Degree | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Founder Director/Board Member | |
| Universida de Alcalá de Henares | College/University | Doctorate Degree Undergraduate Degree | |
| Institut de hautes études internationales et du développement | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The World Bank Group
 The World Bank Group SupranationalGovernment Promotes private investments in developing countries | Supranational | Chairman Corporate Officer/Principal | |
| International Monetary Fund | General Government | Chairman Corporate Officer/Principal | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roche Pharma AG
 Roche Pharma AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma AG is a world leader in innovative cancer drugs and has brought many highly effective drugs onto the market. The company is based in Grenzach-Wyhlen, Germany. The German company also focuses on viral infections, metabolic, central nervous system disorders, and inflammatory diseases. Roche Diagnostics, a subsidiary of Roche Pharma, develops diagnostic tests, instruments, and digital solutions to transform healthcare globally. Roche has been committed to improving lives since its founding in 1896 and creates innovative medicines and diagnostic tests that help millions of patients worldwide. | Medical Distributors | Director/Board Member Chairman | |
Roche Deutschland Holding GmbH
 Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The CEOs are Claudia Fleischer, Hagen Pfundner, Ulrich Winkel. The company was founded in 1997 by Fritz Hoffmann-La Roche. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Swisscontact, Schweizerische Stiftung für technische
 Swisscontact, Schweizerische Stiftung für technische Miscellaneous Commercial ServicesCommercial Services Swisscontact, Schweizerische Stiftung für technische Entwicklungszusammenarbeit promotes sustainable economic growth in developing countries. It promotes economic, social, and environmental development by supporting people in their efforts to integrate into local economic life by developing their skills to secure employment or start a business. The company was founded in 1959 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ETH Zürich Foundation
 ETH Zürich Foundation Investment Trusts/Mutual FundsMiscellaneous ETH Zürich Foundation engages in promoting teaching and research. It specializes in developing new professorships, providing scholarship's, research, teaching and infrastructure facilities. The company was founded in 2003 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
| Humer Foundation | Chairman Director/Board Member | ||
Roche Diagnostics AG
 Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Medical Specialties | Director of Finance/CFO Chief Executive Officer |
Statistics
International
| United States | 17 |
| Switzerland | 17 |
| Germany | 8 |
| Spain | 4 |
| France | 3 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 7 |
| Commercial Services | 4 |
| Government | 3 |
Operational
| Director/Board Member | 587 |
| Corporate Officer/Principal | 246 |
| Chairman | 172 |
| Independent Dir/Board Member | 105 |
| Chief Executive Officer | 90 |
Most connected contacts
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Franz Humer | 45 |
| Bradley Bolzon | 41 |
| Jean-Luc Bélingard | 40 |
| Elaine Jones | 37 |
| Ellen Zane | 32 |
| Wolfgang Ruttenstorfer | 29 |
| Erich Hunziker | 28 |
| Florent Gros | 28 |
| Hans-Peter Hasler | 28 |
| John Bell | 27 |
| Carole Nüchterlein | 26 |
| Gottlieb A. Keller | 26 |
| Silvio Inderbitzin | 25 |
| Patrick J. Fortune | 24 |
- Stock Market
- Insiders
- Eduard Enrico Holdener
- Company connections
